SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Speaking at the J.P. Morgan Healthcare Conference 2026, CEO Daniel O’Day said that the company has seven pipeline drugs for ...

HIV and stigma remain baked into queer dating culture, leaving many men living with the virus to navigate rejection, ...

Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention ...

Human Immunodeficiency Virus (HIV) is a virus that attacks the body’s immune system, specifically the CD4 (T) cells, which ...

A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering ...

Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO ...

Though an antiretroviral medication called PrEP provides near-perfect protection against HIV, patients must often surmount ...

Kenya has taken a major step towards expanding HIV prevention options after the Ministry of Health formally recommended the ...

Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...

In 2026, Oropouche outbreaks will likely continue to affect travelers in the Americas. The biting midge that carries ...

That experience moved Hurley to seek out PrEP, shorthand for preexposure prophylaxis. The antiretroviral medication greatly ...